Recent advances in pharmacological research on the management of irritable bowel syndrome

논문상세정보
    • 저자 남윤진 민영실 손의동
    • 제어번호 105927490
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 41 No. 10 [ 2018 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 955-966 ( 12쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)

' Recent advances in pharmacological research on the management of irritable bowel syndrome' 의 참고문헌

  • toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells
    Schaefer TM [2004]
  • Update on Rome IV criteria for colorectal disorders: implications for clinical practice
    Simren M [2017]
  • Type-specific localization of monoamine oxidase in the enteric nervous system: relationship to 5-hydroxytryptamine, neuropeptides, and sympathetic nerves
    Gershon MD [1990]
  • Trimebutine as a modulator of gastrointestinal motility
    Lee HT [2011]
  • Treatment of irritable bowel syndrome in China: a review
    Li CY [2015]
  • Translating 5-HT receptor pharmacology
    Sanger GJ [2009]
  • Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products
    Chowdhury P [2006]
  • Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation
    Hausmann M [2002]
  • The role in spawning of a putative serotonin receptor isolated from the germ and ciliary cells of the gonoduct in the gonad of the Japanese scallop, Patinopecten yessoensis
    Tanabe T [2010]
  • The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations
  • The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanolinduced conditioned place preference in mice
    Bahi A [2015]
  • The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
    Klooker TK [2010]
  • The irritable bowel severity scoring system : a simple method of monitoring irritable bowel syndrome and its progress
    Francis CY [1997]
  • The effects of Fructus Aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract
    Jiang Y [2014]
  • The effect of Flos Lonicerae Japonicae extract on gastro-intestinal motility function
    Nam Y [2016]
  • The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
    Camilleri M [2012]
  • The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)
    Min YW [2015]
  • TLR2: cellular sensor for microbial and endogenous molecular patterns
  • TLR signaling tailors innate immune responses in human microglia and astrocytes
    Jack CS [2005]
  • Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders
    Tack J [2012]
  • Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver
  • Sleep disorders in functional dyspepsia and future therapy
    Futagami S [2013]
  • Site and mechanism of morphine tolerance in the gastrointestinal tract
    Akbarali HI [2014]
  • Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
    Mawe GM [2013]
  • Serotonergic modulation and irritable bowel syndrome
    Borman R [2001]
  • Serotonergic agents and the irritable bowel syndrome: what goes wrong?
    Spiller R [2008]
  • Rome Foundation-Asian working team report: Asian functional gastrointestinal disorder symptom clusters
    Siah KTH [2017]
  • Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype
    Belmonte L [2012]
  • Role of serotonin 5-HT(3) receptors in intestinal inflammation
    Kato S [2013]
  • Role of histamine H4 receptors in the gastrointestinal tract
    Coruzzi G [2012]
  • Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology
    Browning KN [2015]
  • Review of rifaximin: latest treatment frontier for irritable bowel syndrome mechanism of action and clinical profile
    Gupta K [2017]
  • Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics
    de Kivit S [2014]
  • Regional functional specialization and inhibitory nitrergic and nonnitrergic coneurotransmission in the human esophagus
    Lecea B [2011]
  • Reduction of chronic abdominal pain in patients with inflammatory bowel disease through transcranial direct current stimulation: a randomized controlled trial
    Volz MS [2016]
  • Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
    Cremonini F [2012]
  • Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function
    Bayer SB [2017]
  • Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors
    Jin JG [1999]
  • Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis
    Klem F [2017]
  • Potentiation of motilin-induced contraction by nitric oxide synthase inhibition in the isolated chicken gastrointestinal tract
    Kitazawa T [2002]
  • Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications
    Zhu LL [2012]
  • Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial
  • Patterns of alternation in irritable bowel syndrome
    Chira A [2016]
  • Pathogen-associated molecular pattern contamination as putative endogenous ligands of toll-like receptors
    Tsan MF [2007]
  • Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-D
    Moore NA [2013]
  • PDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality
    Gunaje JJ [2011]
  • No effects of gluten in patients with selfreported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates
  • New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders
    Manabe N [2010]
  • Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome
    Gershon MD [2005]
  • Multiple signal transduction pathways mediated by 5-HT receptors
    Noda M [2004]
  • Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception
    Khasabov SG [1999]
  • Modifications in bacterial groups and short chain fatty acid production in the gut of healthy adult rats after long-term consumption of dietary Maillard reaction products
  • Mechanisms involved in the antinociceptive and anti-inflammatory effects of bis selenide in mice
    Jesse CR [2009]
  • Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials
    Spiegel BM [2010]
  • Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome
    Barbara G [2007]
  • Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients
  • Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex vivo organ culture model of post-infectious irritable bowel syndrome
    Compare D [2017]
  • Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences
    Chang L [2010]
  • Is irritable bowel syndrome an inflammatory disorder?
  • Is diarrhea-predominant irritable bowel syndrome a low-grade gut inflammatory disorder?
    Ghoshal UC [2012]
  • Irritable bowel syndrome: the role of gut neuroendocrine peptides
    El-Salhy M [2012]
  • Irritable bowel syndrome: recent and novel therapeutic approaches
    Andresen V [2006]
  • Irritable bowel syndrome: new agents targeting serotonin receptor subtypes
    De Ponti F [2001]
  • Irritable bowel syndrome: is it "irritable brain" or "irritable bowel"?
    Padhy SK [2015]
  • Irritable bowel syndrome: an integrated explanatory model for clinical practice
    Hungin AP [2015]
  • Irritable bowel syndrome: an infectious disease?
    Quigley EM [2017]
  • Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis
    Stark D [2007]
  • Irritable bowel syndrome: a gut microbiota-related disorder
    Bhattarai Y [2017]
  • Irritable bowel syndrome
    Ford AC [2017]
  • Involvement of different receptors in the central and peripheral effects of histamine on intestinal motility in the rat
    Fargeas MJ [1989]
  • Intestinal microbiome-gut-brain axis and irritable bowel syndrome
    Moser G [2017]
  • Intestinal epithelial suppressor of cytokine signaling 3 enhances microbialinduced inflammatory tumor necrosis factor-alpha, contributing to epithelial barrier dysfunction
    Thagia I [2015]
  • Insights into the mechanisms underlying colonic motor patterns
    Spencer NJ [2016]
  • Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation
    Gilet M [2014]
  • Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways
    Gan AM [2013]
  • Increased expression of toll-like receptors 4, 5, and 9 in small bowel mucosa from patients with irritable bowel syndrome
    Dlugosz A [2017]
  • In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure
    Meiler F [2008]
  • Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1
    Heredia DJ [2013]
  • Immune response in irritable bowel syndrome: a systematic review of systemic and mucosal inflammatory mediators
  • Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients
    Hughes PA [2014]
  • Hydrogen sulfide-induced enhancement of gastric fundus smooth muscle tone is mediated by voltage-dependent potassium and calcium channels in mice
    Meng XM [2015]
  • Histamine responses of large neostriatal interneurons in histamine H1 and H2 receptor knock-out mice
    Ogawa S [2009]
  • Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice
    Wang KY [2010]
  • Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
    Jutel M [2001]
  • Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome
    Wouters MM [2016]
  • Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity
    Deiteren A [2014]
  • Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling
    Anitha M [2012]
  • Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial
  • Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis
    Lovell RM [2012]
  • Gastrointestinal tract disorders in the elderly
    Durazzo M [2017]
  • Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
    Saulnier DM [2011]
  • Gastric acid secretion in L-histidine decarboxylase-deficient mice
    Tanaka S [2002]
  • Functional bowel disorders
  • Functional CRF receptors in BON cells stimulate serotonin release
  • Extensive projections of myenteric serotonergic neurons suggest they comprise the central processing unit in the colon
    Okamoto T [2014]
  • Evidence-based clinical practice guidelines for irritable bowel syndrome
    Fukudo S [2015]
  • Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment
    Zhang R [2011]
  • Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine
    Lee KJ [2011]
  • Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
    Zheng Y [2017]
  • Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum
    Tonini M [1989]
  • Drugs acting on serotonin receptors for the treatment of functional GI disorders
    Tonini M [2006]
  • Dopamine and serotonin receptors mediating contractions of the snail, Helix pomatia, salivary duct
    Kiss T [2003]
  • Diverse signalling by 5-hydroxytryptamine (5-HT) receptors
    Pauwels PJ [2000]
  • Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study
    Koloski NA [2015]
  • Differential expression of toll-like receptors in patients with irritable bowel syndrome
    Brint EK [2011]
  • Dietary and pharmacological treatment of abdominal pain in IBS
    Camilleri M [2017]
  • Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial
    Bohn L [2015]
  • Cytokines and irritable bowel syndrome: where do we stand?
  • Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies
    Jadallah KA [2014]
  • Colorectal distention induces acute and delayed visceral hypersensitivity: role of peripheral corticotropin-releasing factor and interleukin-1 in rats
    Nozu T [2015]
  • Colonic diverticular disease: abnormalities of neuromuscular function
    Bassotti G [2012]
  • Clinical development of histamine H4 receptor antagonists
    Thurmond RL [2017]
  • Chronic visceral hypersensitivity renders defecation more susceptible to stress via a serotonergic pathway in rats
    Nishiyama H [2004]
  • Chronic diarrhea: pathogenesis and therapy
    Krums LM [2002]
  • Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions
    Browning KN [2014]
  • Brainstem circuits regulating gastric function
    Travagli RA [2006]
  • Bowel Disorders
    Lacy BE [2016]
  • Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome
    Mujagic Z [2017]
  • Automatic segmentation of the colon for virtual colonoscopy
    Wyatt CL [2000]
  • Anatomical registration and three-dimensional visualization of low and high-resolution pan-colonic manometry recordings
    Davidson JB [2011]
  • Analysis of purinergic and cholinergic fast synaptic transmission to identified myenteric neurons
    Nurgali K [2003]
  • American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.
    Ford AC [2014]
  • Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders
    Bravo JA [2011]
  • Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats
    Painsipp E [2009]
  • Advances in IBS 2016: a review of current and emerging data
  • Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation
    Johnson AC [2005]
  • Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome
    Buhner S [2009]
  • Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity
    Hoffman JM [2012]
  • Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
    Barbara G [2004]
  • A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties
    Thurmond RL [2004]
  • A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study
    Choung RS [2008]
  • A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function
  • 5-hydroxytryptaminemediated neurotransmission modulates spontaneous and vagal-evoked glutamate release in the nucleus of the solitary tract effect of uptake blockade
    Hosford PS [2014]
  • 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice
    Wang L [2007]
  • 5-Hydroxytryptamine 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine
    Grider JR [1998]
  • 5-HT4 receptor agonists: similar but not the same
  • 5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
    Sia TC [2013]
  • 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons
    Pan H [1994]
  • 5-HT(3) and 5-HT(4) receptors contribute to the anti-motility effects of Garcinia buchananii bark extract in the guinea-pig distal colon
    Boakye PA [2012]